May 28 |
7 Penny Biotech Stocks to Triple Your Investment
|
May 23 |
Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024
|
May 17 |
Small-Cap Sensations: 3 Stocks Under $10 With 10X Potential
|
May 14 |
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
|
May 14 |
Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates
|
Apr 24 |
Wall Street Analysts Believe Affimed N.V. (AFMD) Could Rally 146.73%: Here's is How to Trade
|
Apr 24 |
Affimed Announces Acceptance of AFM24 Clinical Abstract at the 2024 Annual Meeting of the American Society of Clinical Oncology
|
Apr 17 |
Affimed N.V. (AFMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
|